Two hedge fund superstars are still holding loads of Valeant stock
Reuters/ Jeff Zelevansky
As of the end of the third quarter, Omega was holding 484,915 Valeant shares worth over $86 million.
Paulson & Co. sold 110,000 shares of the stock in Q3, but is still holding about 8.9 million shares of the stock worth $1.6 billion.
Valeant Pharmaceuticals' stock has lost over 50% of its value over the last few weeks.
Revelations of shady dealings by its former partner specialty pharmacy - a pharmacy that distributes products and takes care of insurance billing for big drug companies - and state and federal investigations into the Valeant's drug price increases have sent investors running for the exits.
Valeant shares closed Monday down 2.86%, at a price of $73.29. At the start of the third quarter they were worth around $232, and they closed the quarter at $178.
- Fresh photographs of Milky Way’s black hole Sgr A* reveal strong, twisted magnetic field similar to M87*
- 8 Lesser-known places to explore in Himachal Pradesh
- Markets end FY24 on buoyant note amid positive global cues
- SRM Contractors IPO allotment – How to check allotment, GMP, listing date and more
- Rupee falls 6 paise to settle at 83.39 against US dollar